Stock KTTA PASITHEA THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Pasithea Therapeutics Corp.

Equities

KTTA

US70261F2020

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-09 pm EDT 		5-day change 1st Jan Change
7.68 USD +8.93% Intraday chart for Pasithea Therapeutics Corp. +10.98% +3.78%
Apr. 24 Pasithea Therapeutics Corp. Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers CI
Mar. 29 Pasithea Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PASITHEA THERAPEUTICS CORP. Stock Pasithea Therapeutics Corp.
 8.01M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. KTTA Stock
  4. Charts Pasithea Therapeutics Corp.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW